Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mardien Oudega

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|March 26, 2015
Repeated dose titration versus age-based method in electroconvulsive therapy: a pilot studyJan Jaap Aten, Mardien Oudega, Eric van Exel, et al.
JMIR Formative Research|July 3, 2026
Digital Cognitive Behavioral Therapy for Older Adults With Symptoms of Depression: Feasibility Cohort StudyKhadicha Amarti, Mieke H J Schulte, Annet Kleiboer, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 11, 2021
Impact of Inflammation on Cognitive Functioning After Electroconvulsive Therapy in Older Patients with Depression with and Without White Matter HyperintensitiesAngela Carlier, Annemiek Dols, Mardien Oudega, et al.
JMIR Research Protocols|October 25, 2022
Feasibility of Digital Cognitive Behavioral Therapy for Depressed Older Adults With the Moodbuster Platform: Protocol for 2 Pilot Feasibility StudiesKhadicha Amarti, Mieke H J Schulte, Annet Kleiboer, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 21, 2023
The Cortisol Awakening Response as a Biomarker for Cognitive Side-Effects of Electroconvulsive TherapyThomas C Feenstra, Eldon K J la Cruz, Jasmien Obbels, et al.
Journal of Affective Disorders|April 28, 2026
The interplay between affective and cognitive symptoms in difficult-to-treat depression: A symptom network analysisMelissa G Zandstra, Metten Somers, Esmée Verwijk, et al.
Psychological Medicine|July 24, 2023
Development and validation of a multimodal neuroimaging biomarker for electroconvulsive therapy outcome in depression: a multicenter machine learning analysisWillem Benjamin Bruin, Leif Oltedal, Hauke Bartsch, et al.
Frontiers in Psychiatry|August 1, 2022
Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methodsMarieke J Henstra, Thomas C Feenstra, Rob M Kok, et al.
Brain Communications|June 9, 2025
Differentiating sporadic frontotemporal dementia from late-onset primary psychiatric disordersSterre C M de Boer, Lina Riedl, Simon Braak, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Archives of Psychiatry and Clinical Neuroscience|March 26, 2015
Repeated dose titration versus age-based method in electroconvulsive therapy: a pilot studyJan Jaap Aten, Mardien Oudega, Eric van Exel, et al.
JMIR Formative Research|July 3, 2026
Digital Cognitive Behavioral Therapy for Older Adults With Symptoms of Depression: Feasibility Cohort StudyKhadicha Amarti, Mieke H J Schulte, Annet Kleiboer, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 11, 2021
Impact of Inflammation on Cognitive Functioning After Electroconvulsive Therapy in Older Patients with Depression with and Without White Matter HyperintensitiesAngela Carlier, Annemiek Dols, Mardien Oudega, et al.
JMIR Research Protocols|October 25, 2022
Feasibility of Digital Cognitive Behavioral Therapy for Depressed Older Adults With the Moodbuster Platform: Protocol for 2 Pilot Feasibility StudiesKhadicha Amarti, Mieke H J Schulte, Annet Kleiboer, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 21, 2023
The Cortisol Awakening Response as a Biomarker for Cognitive Side-Effects of Electroconvulsive TherapyThomas C Feenstra, Eldon K J la Cruz, Jasmien Obbels, et al.
Journal of Affective Disorders|April 28, 2026
The interplay between affective and cognitive symptoms in difficult-to-treat depression: A symptom network analysisMelissa G Zandstra, Metten Somers, Esmée Verwijk, et al.
Psychological Medicine|July 24, 2023
Development and validation of a multimodal neuroimaging biomarker for electroconvulsive therapy outcome in depression: a multicenter machine learning analysisWillem Benjamin Bruin, Leif Oltedal, Hauke Bartsch, et al.
Frontiers in Psychiatry|August 1, 2022
Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methodsMarieke J Henstra, Thomas C Feenstra, Rob M Kok, et al.
Brain Communications|June 9, 2025
Differentiating sporadic frontotemporal dementia from late-onset primary psychiatric disordersSterre C M de Boer, Lina Riedl, Simon Braak, et al.
Pageof 1